validated 0-8C hold
A modular cold-chain system that becomes a product patients keep.
POLARCYL keeps medication safely cold for nearly two days, then turns the shipping container into reusable hot/cold drinkware - engineered as a shipping system first, and a keepsake second.
margin over 24h need
configurations tested
Cold-chain shipping is expensive, wasteful, and still risky.
Overnight shipping, every time
Disposable coolers struggle to hold temperature past 24 hours, forcing pharmacies toward expensive expedited service for cold-chain shipments.
Single-use packaging waste
Foam coolers and gel packs are thrown away on arrival: no reuse value, no brand impression, and more landfill.
Real excursion risk
Generic gel packs sweep through a wide temperature curve, creating freeze risk on one end and early warm-up on the other.
One housing. Four interchangeable cold-chain payload formats.
Each cylinder shares the same outer envelope, so every variant drops into the same 500mL tumbler while matching the vial or pen format inside.
Housing (10)
500mL304 stainless steel, vacuum-insulated tumbler body.
PCM cylinder (20)
IndexedInterchangeable cylinders matched to vial and pen formats.
Payload (30)
2R / 6R / 10R / PenThree, four, or five vial loads plus injector-pen support.
Reuse
Patient keepsCylinder removed on arrival; tumbler remains as reusable drinkware.
Independently tested against 23 configurations.
On the strength of this data, POLARCYL was adopted as the primary cold-ship rollout configuration by a qualification pharmacy partner.
Longest 0-8C hold
Validated on a live ground-shipping lane.
Summer challenge hold
Cold-chain hold under a 30-35C worst-case challenge.
<=25C backstop
Extended controlled-room-temperature protection as a robustness margin.
Rollout configuration
Adopted by a qualification pharmacy partner as the standard shipping experience.
Simulated live thermometer
+8.0C +46.4FUpper refrigerated boundary reached, still inside allowed compliance window.
Engineered from a drawing set, not assembled from generic parts.
Patent pending
Invention disclosure covers the modular interchangeable-cylinder system, blind-bore geometry, and dual-use structural design.
Third-party validated
The 41.22-hour result was independently confirmed against 23 competing configurations, not self-reported.
Manufacturing structure
IP ownership is held by POLARCYL LLC with manufacturing secured under confidentiality and non-circumvention terms.
One housing. Four interchangeable cylinders.
2R variant
5 vialsSmall-volume compounds.
6R variant
4 vialsStandard peptide vials.
10R variant
3 vialsLarger-volume preparations.
Pen injector
1 penPen-format payload.
A shipping cost story - and a brand story.
POLARCYL can move eligible shipments off overnight carriers and onto standard ground service, while every retained tumbler becomes a durable brand touchpoint after delivery.
Built different from disposable packaging
Small box, faster tier - same cold-chain result
Illustrative FedEx One Rate comparison from the source deck. Actual savings depend on zone, negotiated rates, and alternative box size.
A branded unboxing, not just a shipment.
The outer box, vial sleeve, tumbler, and support materials can carry one mark, presenting cold-chain fulfillment as a considered patient experience.
Co-branded or private label
Pharmacy clients can present the kit under their own brand.
Compliance-forward
Refrigeration instructions and sensitive labeling are built into the package.
Marketing asset
The kit protects the shipment and doubles as a premium first impression.
Let's build the cold-chain standard.
POLARCYL is ready for its next manufacturing, distribution, and qualified pharmacy partners. Confidential data available under partner review.